Orion Biotechnology Canada Ltd. — Form D/A

Orion Biotechnology Canada Ltd. of OTTAWA, ONTARIO, Z4, a company, filed a Form D amendment with the SEC on 2023-03-15. The offering totals $15.0M, of which $9.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Mark HechtDirectorOttawa, A6
Anatolii KlepatskyiDirectorOttawa, A6
Jason William BurkeExecutive OfficerOttawa, A6
Theresa FirestoneExecutive OfficerToronto, A6
Jean William ForcioneExecutive OfficerOttawa, A6
John William JussupExecutive OfficerOttawa, A6
Theresa FirestoneDirectorToronto, A6
John JussupExecutive OfficerOttawa, Ontario, Z4
Lonnel CoatsDirectorOttawa, A6
Anatolii KlepatskyDirectorOttawa, Ontario, Z4
Anatolii KlepatskyExecutive OfficerOttawa, Ontario, Z4
Jean ForcioneDirectorOttawa, Ontario, Z4
Katie HewittDirectorOttawa, A6
Praveen TyleDirectorEncinitas, CA
Praveen TyleExecutive OfficerEncinitas, CA
Bradford SmithDirectorOttawa, Ontario, Z4
Mark GroperDirectorOttawa, Ontario, Z4
Mark GroperExecutive OfficerOttawa, Ontario, Z4
Jason BurkeExecutive OfficerOttawa, Ontario, Z4
Rudolf BomDirectorOttawa, A6
Rudolf BomExecutive OfficerOttawa, A6
Anatole Sheila KlepatskyDirectorOttawa, A6
Anatole Sheila KlepatskyExecutive OfficerOttawa, A6
Thomas Sheila HechtDirectorOttawa, A6
Thomas Sheila HechtExecutive OfficerOttawa, A6

Other filings by this issuer (5)

FiledFormOfferingSold
2025-08-26D/A$15.0M$6.8M
2024-07-23D$5.0M$743K
2021-06-22D/A$15.0M$5.4M
2021-06-15D$15.0M$5.4M
2020-10-09D$605K

More